Device Trial Radar · NCT04179279
Comparative Analysis of a Non-contact Respiratory and Heart Rate Monitor Vs. a Conventional Clinically Validated Reference Monitor
Last checked: Nov 20, 2026Latest source record: Feb 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
130
Actual
Start
Oct 6, 2019
Primary completion
Jan 27, 2020
Study completion Jan 27, 2020
Sponsor
- Lead sponsor
- ContinUse Biometrics Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 27, 2019
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a prospective pivotal study in patients admitted/visiting the cardiology ward and/or outpatient clinics for various indications. The study will be conducted in two stages. The first stage will comprise a pilot study with 10 subjects, which will be completed and analyzed prior to initiation of the second stage. The two studies are independent and are included in the same protocol for logistical reasons. The second stage of the study, which will include 120 subjects, is pivotal and intended to validate the Gili BioSensor System. Testing procedure will include seating the subject in either a steady chair in front of a table, or in bed with the bedrest raised in front of a cardiac table (or similar). The subject will be seated for 5 minutes to reach a physiological steady state. During this time, the subject will be connected to the reference device according to the manufacturer's guidelines. The investigational device will be placed on a stable surface in front of the subject (table / cardiac table or similar) and will point to the left side of the subject's chest. Both the investigational and reference devices will be temporally synchronized to maintain coordinated recording. Following the 5-minute resting period, both investigational and reference devices will be activated for a comparative recording session to acquire at least 180 seconds (3 minutes) of evaluable data. Each 60-sec interval will be used separately for comparative analyses.
Conditions
- Heart Rate
- Respiratory Rate
Interventions
Gili Biosensor System (Gili Pro Biosensor)Device
Non-contact monitoring of heart and respiratory rates using an optical device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Heart rateTime frame: During the procedure
- Respiratory rateTime frame: During the procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tel Aviv Sourasky Medical Center (TASMC)
Tel Aviv, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.